{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:14:44Z","timestamp":1789388084996,"version":"build-2803163510"},"reference-count":63,"publisher":"American Chemical Society (ACS)","issue":"18","license":[{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/100015691","name":"Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI185559"],"award-info":[{"award-number":["R01 AI185559"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["461708005"],"award-info":[{"award-number":["461708005"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004167","name":"Medicines for Malaria Venture","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100004167","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>New treatment strategies are required to combat the spread of drug-resistant Plasmodium falciparum malaria. The synthesis and preclinical evaluation of novel 3-hydroxy-propanamidines (HPAs), with modifications of the phenanthrene and the 4-fluorobenzamidine moieties, has yielded several analogs exhibiting excellent in vitro growth inhibition of drug-sensitive or resistant P. falciparum fresh clinical isolates and culture-adapted strains. No cytotoxicity in the human HepG2 cell line was observed, demonstrating notable parasite selectivity. The most active HPA 7d, which features a 4-bromobenzamidine moiety, inhibited the formation of synthetic hemozoin (\u03b2-hematin) with IC50 values lower than chloroquine and the lead compound TKK130. Additionally, 7d showed a killing rate comparable to chloroquine. In initial in vivo pharmacokinetics, 7d displayed a favorable pharmacokinetic profile, with a fast onset and slow elimination phase. In vivo, 7d demonstrated dose-dependent curative activity after oral administration in the Plasmodium berghei mouse model, without apparent signs of toxicity.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.5c01337","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T21:11:58Z","timestamp":1757365918000},"page":"19229-19248","source":"Crossref","is-referenced-by-count":4,"title":["Structure\u2013Activity\nRelationships of 3-Hydroxypropanamidines\n(HPAs) with Potent In Vivo Antimalarial Activity"],"prefix":"10.1021","volume":"68","author":[{"given":"Saskia","family":"Klein","sequence":"first","affiliation":[{"name":"Heinrich Heine University Du\u0308sseldorf , , ,","place":["Du\u0308sseldorf, Germany, 40225"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Moritz","sequence":"additional","affiliation":[{"name":"University of Muenster , , ,","place":["Muenster, Germany, 48149"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lais","family":"Pessanha de Carvalho","sequence":"additional","affiliation":[{"name":"Eberhard Karls University Tuebingen , , ,","place":["Tuebingen, Germany, 72074"]},{"name":"Columbia University Irving Medical Center , , , ,","place":["New York, New York, United States, 10032"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja C.","family":"Knaab","sequence":"additional","affiliation":[{"name":"Ludwig Maximilians University Mu\u0308nchen , , ,","place":["Mu\u0308nchen, Germany, 81377"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Lungerich","sequence":"additional","affiliation":[{"name":"University of Muenster , , ,","place":["Muenster, Germany, 48149"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Meyer","sequence":"additional","affiliation":[{"name":"Heinrich Heine University Du\u0308sseldorf , , ,","place":["Du\u0308sseldorf, Germany, 40225"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jona","family":"Sandstro\u0308m","sequence":"additional","affiliation":[{"name":"Heinrich Heine University Du\u0308sseldorf , , ,","place":["Du\u0308sseldorf, Germany, 40225"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Thibaud","sequence":"additional","affiliation":[{"name":"Stellenbosch University , , ,","place":["Matieland, South Africa, 7602"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2932-395X","authenticated-orcid":true,"given":"Katherine A.","family":"de Villiers","sequence":"additional","affiliation":[{"name":"Stellenbosch University , , ,","place":["Matieland, South Africa, 7602"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Fidock","sequence":"additional","affiliation":[{"name":"Columbia University Irving Medical Center , , , ,","place":["New York, New York, United States, 10032"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0811-0912","authenticated-orcid":true,"given":"Sergio","family":"Wittlin","sequence":"additional","affiliation":[{"name":"Swiss Tropical and Public Health Institute , ,","place":["Allschwil, Switzerland, CH-4123"]},{"name":"University of Basel , ,","place":["Basel, Switzerland, CH-4003"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Rottmann","sequence":"additional","affiliation":[{"name":"Swiss Tropical and Public Health Institute , ,","place":["Allschwil, Switzerland, CH-4123"]},{"name":"University of Basel , ,","place":["Basel, Switzerland, CH-4003"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7970-1429","authenticated-orcid":true,"given":"Jana","family":"Held","sequence":"additional","affiliation":[{"name":"Eberhard Karls University Tuebingen , , ,","place":["Tuebingen, Germany, 72074"]},{"name":"German Center for Infection Research , Partner Site Tu\u0308bingen , ,","place":["Tu\u0308bingen, Germany, 72074"]},{"name":"Centre de Recherches Me\u0301dicales de Lambare\u0301ne\u0301 , ,","place":["Lambare\u0301ne\u0301, Gabon, B.P. 242"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1782-9937","authenticated-orcid":true,"given":"Bjoern B.","family":"Burckhardt","sequence":"additional","affiliation":[{"name":"University of Muenster , , ,","place":["Muenster, Germany, 48149"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9474-4224","authenticated-orcid":true,"given":"Thomas","family":"Kurz","sequence":"additional","affiliation":[{"name":"Heinrich Heine University Du\u0308sseldorf , , ,","place":["Du\u0308sseldorf, Germany, 40225"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"issue":"5","key":"2026073102142511400_cit1","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1590\/0074-0276130597","article-title":"The Plasmodium\nBottleneck: Malaria Parasite Losses in the Mosquito Vector","volume":"109","author":"Smith","year":"2014","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"2026073102142511400_cit2","unstructured":"World Health Organization.\n          .  World Malaria Report 2024: Addressing Inequity\nin the Global Malaria Response, Licence: CC BY-NC-SA 3.0 IGO; World Health Organization: Geneva, 2024."},{"key":"2026073102142511400_cit3","unstructured":"World Health Organization.\n          \n          Child Mortality (under 5 Years); World Health Organization: Geneva, 2021. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/levels-and-trends-in-child-under-5-mortality-in-2020 (accessed Apr 04, 2025)."},{"key":"2026073102142511400_cit4","unstructured":"University of Oxford.\n          \n          New Phase 3 Trial Data Confirm Uniquely High\nEfficacy and Good Safety Profile of R21\/Matrix-M Malaria Vaccine; University of Oxford, 2024. https:\/\/www.ox.ac.uk\/news\/2024-02-01-new-phase-3-trial-data-confirm-uniquely-high-efficacy-and-good-safety-profile (accessed Apr 11, 2025)."},{"key":"2026073102142511400_cit5","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/s0140-6736(23)02511-4","article-title":"Safety and efficacy of malaria vaccine candidate R21\/Matrix-M in\nAfrican children: a multicentre, double-blind, randomised, phase 3\ntrial","volume":"403","author":"Datoo","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"2026073102142511400_cit6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12936-024-04846-w","article-title":"A Perspective on Oxford\u2019s\nR21\/Matrix-MTM Malaria Vaccine and the Future of Global\nEradication Efforts","volume":"23","author":"Aderinto","year":"2024","journal-title":"Malar. J."},{"key":"2026073102142511400_cit7","doi-asserted-by":"publisher","first-page":"102193","DOI":"10.1016\/j.mib.2022.102193","article-title":"Plasmodium\nFalciparum Resistance\nto Artemisinin-Based Combination Therapies","volume":"69","author":"Ward","year":"2022","journal-title":"Curr. Opin. Microbiol."},{"key":"2026073102142511400_cit8","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-031-15848-3","volume-title":"Malarial Drug Delivery\nSystems: Advances in Treatment of Infectious Diseases","author":"Shegokar","year":"2023"},{"issue":"10","key":"2026073102142511400_cit9","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41573-023-00772-9","article-title":"Antimalarial Drug Discovery: Progress and Approaches","volume":"22","author":"Siqueira-Neto","year":"2023","journal-title":"Nat. Rev. Drug Discovery"},{"key":"2026073102142511400_cit10","doi-asserted-by":"publisher","first-page":"202400460","DOI":"10.1002\/cbdv.202400460","article-title":"Exploring\nthe Recent Pioneering Developments of Small Molecules in Antimalarial\nDrug Armamentarium: A Chemistry Prospective Appraisal","volume":"21","author":"Bagratee","year":"2024","journal-title":"Chem. Biodiversity"},{"key":"2026073102142511400_cit11","unstructured":"European Medicines Agency.\n          \n          Pyramax\u2500Opinion\non Medicine\nfor Use Outside the EU, 2022. https:\/\/www.ema.europa.eu\/en\/opinion-medicine-use-outside-EU\/human\/pyramax (accessed April 22, 2025)."},{"issue":"6","key":"2026073102142511400_cit12","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1021\/acs.jmedchem.0c01744","article-title":"3-Hydroxy-Propanamidines,\na New Class of Orally Active Antimalarials Targeting Plasmodium Falciparum","volume":"64","author":"Knaab","year":"2021","journal-title":"J. Med. Chem."},{"issue":"1","key":"2026073102142511400_cit13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1021\/acs.jmedchem.4c01465","article-title":"TKK130 Is a 3-Hydroxy-Propanamidine (HPA) with Potent Antimalarial\nIn Vivo Activity and a High Barrier to Resistance","volume":"68","author":"Knaab","year":"2025","journal-title":"J. Med. Chem."},{"issue":"11","key":"2026073102142511400_cit14","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1055\/s-1989-27423","article-title":"Ozonolysis\nof Quinolines: A Versatile Synthesis of Polyfunctional Pyridines","volume":"1989","author":"O\u2019Murchu","year":"1989","journal-title":"Synthesis"},{"key":"2026073102142511400_cit15","unstructured":"Knaab, T. C.\n          \n          Synthese Und\nAntiplasmodiale Evaluation Neuer Arylaminoalkohol Analoga. Ph.D. Thesis, Heinrich-Heine-Universita\u0308t\nDu\u0308sseldorf, 2018."},{"issue":"8","key":"2026073102142511400_cit16","doi-asserted-by":"publisher","first-page":"5805","DOI":"10.1021\/acs.joc.1c00256","article-title":"Selective Synthesis of Dihydrophenanthridine\nand Phenanthridine Derivatives from the Cascade Reactions of o -Arylanilines\nwith Alkynoates through C\u2013H\/N\u2013H\/C\u2013C Bond Cleavage","volume":"86","author":"Xu","year":"2021","journal-title":"J. Org. Chem."},{"issue":"12","key":"2026073102142511400_cit17","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1021\/acs.orglett.6b01300","article-title":"Synthesis\nof Fluorenes Starting from 2-Iodobiphenyls and CH 2 Br 2 through Palladium-Catalyzed\nDual C\u2013C Bond Formation","volume":"18","author":"Shi","year":"2016","journal-title":"Org. Lett."},{"issue":"17","key":"2026073102142511400_cit18","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.tetlet.2012.02.080","article-title":"Heterocyclic\nCarbene-Catalyzed Cyanomethylation of Aldehydes with TMSAN","volume":"53","author":"Fan","year":"2012","journal-title":"Tetrahedron Lett."},{"issue":"31","key":"2026073102142511400_cit19","doi-asserted-by":"publisher","first-page":"7926","DOI":"10.1002\/chem.201800078","article-title":"Flexible Versus Rigid\nG-Quadruplex\nDNA Ligands: Synthesis of Two Series of Bis-indole Derivatives and\nComparison of Their Interactions with G-Quadruplex DNA","volume":"24","author":"Prasad","year":"2018","journal-title":"Chem.\u2500A Eur. J."},{"key":"2026073102142511400_cit20","doi-asserted-by":"publisher","first-page":"5474","DOI":"10.1002\/ejoc.201601191","article-title":"Synthesis of the Carbazole Scaffold Directly from 2-Aminobiphenyl\nby Means of Tandem C\u2013H Activation and C\u2013N Bond Formation","volume":"2016","author":"Bj\u00f8rsvik","year":"2016","journal-title":"Eur. J. Org. Chem."},{"issue":"9","key":"2026073102142511400_cit21","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1070\/RC1970v039n09ABEH002020","article-title":"Polyphosphoric Acid in Cyclisation\nand Polycyclisation Reactions","volume":"39","author":"Krongauz","year":"1970","journal-title":"Russ. Chem. Rev."},{"issue":"4","key":"2026073102142511400_cit22","doi-asserted-by":"publisher","first-page":"953","DOI":"10.3987\/COM-02-9702","article-title":"Improved oxidation\nof active methyl group of N-heteroaromatic compounds by selenium dioxide\nin the presence of tert-butyl hydroperoxide","volume":"60","author":"Tagawa","year":"2003","journal-title":"Heterocycles"},{"issue":"62","key":"2026073102142511400_cit23","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1021\/cr60115a001","article-title":"Selenium dioxide:\nPreparation, properties, and use\nas oxidizing agent","volume":"36","author":"Waitkins","year":"1945","journal-title":"Chem. Rev."},{"key":"2026073102142511400_cit24","unstructured":"Leven, M.\n          \n          Synthese Und Antimikrobielle\nEigenschaften von N-Aminooxyalkylsubstituierten 8-Aminochinolinen\nUnd 3-Hydroxypropanhydrazonamiden. Ph.D. Thesis, Heinrich-Heine-Universita\u0308t Du\u0308sseldorf, 2013."},{"issue":"14","key":"2026073102142511400_cit25","doi-asserted-by":"publisher","first-page":"6036","DOI":"10.1021\/acs.jmedchem.7b00140","article-title":"3-Hydroxy- N \u2032-Arylidenepropanehydrazonamides\nwith Halo-Substituted Phenanthrene Scaffolds Cure P. Berghei Infected\nMice When Administered Perorally","volume":"60","author":"Leven","year":"2017","journal-title":"J. Med. Chem."},{"issue":"2","key":"2026073102142511400_cit26","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1021\/jo1021426","article-title":"Copper-Catalyzed\nIntramolecular C\u2013N\nBond Formation: A Straightforward Synthesis of Benzimidazole Derivatives\nin Water","volume":"76","author":"Peng","year":"2011","journal-title":"J. Org. Chem."},{"issue":"1","key":"2026073102142511400_cit27","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12936-019-2724-z","article-title":"The Past, Present and Future of Anti-Malarial\nMedicines","volume":"18","author":"Tse","year":"2019","journal-title":"Malar. J."},{"issue":"23","key":"2026073102142511400_cit28","doi-asserted-by":"publisher","first-page":"10526","DOI":"10.1021\/acs.jmedchem.9b00761","article-title":"The Development\nProcess for Discovery and Clinical Advancement of Modern Antimalarials","volume":"62","author":"Ashton","year":"2019","journal-title":"J. Med. Chem."},{"issue":"7556","key":"2026073102142511400_cit29","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature14451","article-title":"A Novel Multiple-Stage Antimalarial\nAgent That Inhibits Protein Synthesis","volume":"522","author":"Baragan\u0303a","year":"2015","journal-title":"Nature"},{"issue":"6061","key":"2026073102142511400_cit30","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1126\/science.1211936","article-title":"Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery","volume":"334","author":"Meister","year":"2011","journal-title":"Science"},{"issue":"4","key":"2026073102142511400_cit31","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1128\/AAC.04149-14","article-title":"Subtle Changes in Endochin-Like Quinolone\nStructure Alter the Site of Inhibition within the Cytochrome Bc 1\nComplex of Plasmodium Falciparum","volume":"59","author":"Stickles","year":"2015","journal-title":"Antimicrob.\nAgents Chemother."},{"issue":"50","key":"2026073102142511400_cit32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1414221111","article-title":"(+)-SJ733,\na Clinical Candidate for Malaria That Acts through ATP4 to Induce\nRapid Host-Mediated Clearance of Plasmodium","volume":"111","author":"Jime\u0301nez-Di\u0301az","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"3","key":"2026073102142511400_cit33","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ijpddr.2014.08.002","article-title":"International Journal for Parasitology: Drugs and Drug\nResistance Identification of b -Hematin Inhibitors in a High-Throughput\nScreening Effort Reveals Scaffolds with in Vitro Antimalarial Activity","volume":"4","author":"Sandlin","year":"2014","journal-title":"Int. J. Parasitol.: Drugs Drug Resist."},{"issue":"3","key":"2026073102142511400_cit34","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2174\/138620710790980496","article-title":"Lipophilic\nMediated Assays for \u03b2-Hematin Inhibitors","volume":"13","author":"Carter","year":"2010","journal-title":"Comb. Chem. High Throughput Screening"},{"issue":"1","key":"2026073102142511400_cit35","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1038\/s41598-023-29273-w","article-title":"Identifying\nInhibitors of \u03b2-Haematin Formation with Activity against Chloroquine-Resistant\nPlasmodium Falciparum Malaria Parasites via Virtual Screening Approaches","volume":"13","author":"Amod","year":"2023","journal-title":"Sci. Rep."},{"key":"2026073102142511400_cit36","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202200139","article-title":"Adsorption\nto the Surface of Hemozoin Crystals: Structure-Based Design and Synthesis\nof Amino-Phenoxazine \u03b2-Hematin Inhibitors","volume":"17","author":"Olivier","year":"2022","journal-title":"ChemMedChem"},{"issue":"6775","key":"2026073102142511400_cit37","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/35005132","article-title":"The Structure\nof Malaria Pigment \u03b2-Haematin","volume":"404","author":"Pagola","year":"2000","journal-title":"Nature"},{"issue":"6","key":"2026073102142511400_cit38","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1021\/ci900094m","article-title":"Simple\nSize-Independent Measure of Ligand Efficiency","volume":"49","author":"Nissink","year":"2009","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"2026073102142511400_cit39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-019-3075-5","article-title":"An in Vitro Toolbox\nto Accelerate Anti-Malarial Drug Discovery and Development","volume":"19","author":"Charman","year":"2020","journal-title":"Malar. J."},{"key":"2026073102142511400_cit40","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.molstruc.2013.09.053","article-title":"Clinical Relevance of Drug Binding\nto Plasma Proteins","volume":"1077","author":"Ascenzi","year":"2014","journal-title":"J. Mol. Struct."},{"key":"2026073102142511400_cit41","unstructured":"Food and Drug Administration.\n          \n          Center for\nDrug Evaluation and Research.\nApplication Number 22-268, Coartem (artemether\/lumefantrine) Tablets\nfor Treatment of Uncomplicated Plasmodium falciparum Malaria, 2008. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2009\/022268s000_sumr.pdf (accessed Apr 16, 2025)."},{"key":"2026073102142511400_cit42","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jchromb.2015.01.015","article-title":"Development and validation\nof a LC-MS\/MS method for the quantitation of lumefantrine in mouse\nwhole blood and plasma","volume":"985","author":"Govender","year":"2015","journal-title":"J. Chromatogr. B: Anal.\nTechnol. Biomed. Life Sci."},{"key":"2026073102142511400_cit43","unstructured":"Food and Drug Administration.\n          \n          Coartem (Artemether\/Lumefantrine)\u2500Label, 2009. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/022268lbl.pdf (accessed Apr 16, 2025)."},{"key":"2026073102142511400_cit44","unstructured":"Novartis Pharma.\n          \n          Fachinformation Riamet 20 mg\/120 mg Tabletten, 2023. https:\/\/www.fachinfo.de\/fi\/pdf\/007356\/riamet-20-120-mg-tabletten (accessed Apr 16, 2025)."},{"issue":"8","key":"2026073102142511400_cit45","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1038\/sj.bjp.0703470","article-title":"Inhibition\nof HERG Potassium Channels by the Antimalarial Agent Halofantrine","volume":"130","author":"Tie","year":"2000","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"2026073102142511400_cit46","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ejphar.2003.11.003","article-title":"Inhibition of HERG K+ Currents by Antimalarial Drugs in Stably Transfected\nHEK293 Cells","volume":"484","author":"Traebert","year":"2004","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"2026073102142511400_cit47","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/jcph.1527","article-title":"CYP2B6*6 Genotype\nSpecific\nDifferences in Artemether-Lumefantrine Disposition in Healthy Volunteers","volume":"60","author":"Abdullahi","year":"2020","journal-title":"J. Clin. Pharmacol."},{"issue":"5","key":"2026073102142511400_cit48","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1046\/j.1365-2125.2002.01696.x","article-title":"Pharmacokinetics and Electrocardiographic Pharmacodynamics\nof Artemether-Lumefantrine (Riamet\u00ae) with Concomitant Administration\nof Ketoconazole in Healthy Subjects","volume":"54","author":"Lefe\u0300vre","year":"2002","journal-title":"Br. J.\nClin. Pharmacol."},{"key":"2026073102142511400_cit49","unstructured":"Bristol-Myers Squibb Co.\n          \n          Aryl Amines and Uses\nThereof. WO\n2004083174 A2, 2004."},{"issue":"8","key":"2026073102142511400_cit50","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1128\/AAC.49.8.3575-3577.2005","article-title":"Simple Histidine-Rich Protein 2 Double-Site Sandwich\nEnzyme-Linked Immunosorbent Assay for Use in Malaria Drug Sensitivity\nTesting","volume":"49","author":"Noedl","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"2026073102142511400_cit51","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00085-19","article-title":"Ivermectin Impairs the Development of Sexual and Asexual Stages of\nPlasmodium Falciparum In Vitro","volume":"63","author":"de Carvalho","year":"2019","journal-title":"Antimicrob.\nAgents Chemother."},{"key":"2026073102142511400_cit52","unstructured":"R Core Team.\n          .  R: A Language and Environment for Statistical\nComputing; R Foundation for Statistical Computing: Vienna, 2022."},{"key":"2026073102142511400_cit53","doi-asserted-by":"publisher","first-page":"802294","DOI":"10.3389\/fcimb.2021.802294","article-title":"Boromycin Has Rapid-Onset\nAntibiotic Activity Against Asexual and Sexual Blood Stages of Plasmodium\nFalciparum","volume":"11","author":"de Carvalho","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"2026073102142511400_cit54","article-title":"Chapters 1\u20134, 8: Cell Viability\nAssays","volume-title":"Assay guidance manual","author":"Prabst","year":"2017"},{"issue":"6","key":"2026073102142511400_cit55","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrd1416","article-title":"Antimalarial\nDrug Discovery: Efficacy Models for Compound Screening","volume":"3","author":"Fidock","year":"2004","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"11","key":"2026073102142511400_cit56","doi-asserted-by":"publisher","first-page":"4400","DOI":"10.1073\/pnas.1015762108","article-title":"Synthetic\nOzonide Drug Candidate OZ439 Offers New Hope for a Single-Dose Cure\nof Uncomplicated Malaria","volume":"108","author":"Charman","year":"2011","journal-title":"Proc. Natl. Acad.\nSci. U.S.A."},{"issue":"3","key":"2026073102142511400_cit57","doi-asserted-by":"publisher","first-page":"106894","DOI":"10.1016\/j.ijantimicag.2023.106894","article-title":"Quantification\nof Plasmodium Falciparum HRP-2 as an Alternative Method to [3H]Hypoxanthine\nIncorporation to Measure the Parasite Reduction Ratio in Vitro","volume":"62","author":"de Carvalho","year":"2023","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"7","key":"2026073102142511400_cit58","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/jps.2600790704","article-title":"Assay and Disposition of Carvedilol\nEnantiomers in Humans and Monkeys: Evidence of Stereoselective Presystemic\nMetabolism","volume":"79","author":"Fujimaki","year":"1990","journal-title":"J. Pharm. Sci."},{"issue":"5\u20136","key":"2026073102142511400_cit59","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/bdd.711","article-title":"Prediction\nof Human Blood-to-plasma Drug Concentration Ratio","volume":"31","author":"Uchimura","year":"2010","journal-title":"Biopharm. Drug Dispos."},{"issue":"3","key":"2026073102142511400_cit60","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/dta.2949","article-title":"Low-volume LC\u2013MS\/MS Method for the Pharmacokinetic\nInvestigation of Carvedilol, Enalapril and Their Metabolites in Whole\nBlood and Plasma: Application to a Paediatric Clinical Trial","volume":"13","author":"Gangnus","year":"2021","journal-title":"Drug Test. Anal."},{"issue":"1","key":"2026073102142511400_cit61","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ijpharm.2006.03.007","article-title":"High Throughput\nMicrosomal Stability Assay for Insoluble Compounds","volume":"317","author":"Di","year":"2006","journal-title":"Int. J. Pharm."},{"issue":"9","key":"2026073102142511400_cit62","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1124\/dmd.105.004259","article-title":"A unified model\nfor predicting human\nhepatic, metabolic clearance from in vitro intrinsic clearance data\nin hepatocytes and microsomes","volume":"33","author":"Riley","year":"2005","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"2026073102142511400_cit63","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1208\/s12248-022-00774-2","article-title":"Addressing\nthe Accuracy of Plasma\nProtein Binding Measurement for Highly Bound Compounds Using the Dilution\nMethod","volume":"25","author":"Ryu","year":"2023","journal-title":"AAPS J."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.5c01337","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/68\/18\/19229\/66295413\/acs.jmedchem.5c01337.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/68\/18\/19229\/66295413\/acs.jmedchem.5c01337.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T06:14:39Z","timestamp":1785478479000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/68\/18\/19229\/5234814\/Structure-Activity-Relationships-of-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":63,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2025,9,8]]},"published-print":{"date-parts":[[2025,9,25]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5c01337","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,8]]}}}